Researchers sought to determine whether elevated platelet-to-lymphocyte ratio and plasma C-reactive protein level would help predict prognosis for patients with MDS.
Researchers sought to determine whether patients were equally represented along designated racial groups in FDA drug trails for multiple myeloma.
Researchers sought to determine whether liso-cel would have acceptable toxicity and effectiveness in patients with SLL or CLL.
Researchers sought to determine the effect of transplant-related complications and socioeconomic factors on revaccination schedule adherence among pediatric patients following allo-HSCT.
Researchers sought to determine if there are racial disparities in treatment with bone-modifying agents for patients with multiple myeloma.
Researchers sought to determine whether blinatumomab followed by POMP maintenance chemotherapy would be safe and effective in older patients with B-ALL.
Researchers sought to determine the predictors of mortality during hospital stays in patients with multiple myeloma.
